6-32852191-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BA1
The NM_000593.6(TAP1):c.762C>T(p.Gly254Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0309 in 1,612,982 control chromosomes in the GnomAD database, including 946 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.030 ( 82 hom., cov: 32)
Exomes 𝑓: 0.031 ( 864 hom. )
Consequence
TAP1
NM_000593.6 synonymous
NM_000593.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.91
Publications
15 publications found
Genes affected
TAP1 (HGNC:43): (transporter 1, ATP binding cassette subfamily B member) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is involved in the pumping of degraded cytosolic peptides across the endoplasmic reticulum into the membrane-bound compartment where class I molecules assemble. Mutations in this gene may be associated with ankylosing spondylitis, insulin-dependent diabetes mellitus, and celiac disease. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2014]
PSMB9 (HGNC:9546): (proteasome 20S subunit beta 9) The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 1 (proteasome beta 6 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. [provided by RefSeq, Mar 2010]
PSMB9 Gene-Disease associations (from GenCC):
- proteasome-associated autoinflammatory syndrome 3Inheritance: Unknown Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant 6-32852191-G-A is Benign according to our data. Variant chr6-32852191-G-A is described in ClinVar as Benign. ClinVar VariationId is 466393.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=1.91 with no splicing effect.
BA1
GnomAdExome4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0609 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0298 AC: 4536AN: 152088Hom.: 82 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
4536
AN:
152088
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0313 AC: 7726AN: 246750 AF XY: 0.0330 show subpopulations
GnomAD2 exomes
AF:
AC:
7726
AN:
246750
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0310 AC: 45231AN: 1460776Hom.: 864 Cov.: 33 AF XY: 0.0320 AC XY: 23290AN XY: 726698 show subpopulations
GnomAD4 exome
AF:
AC:
45231
AN:
1460776
Hom.:
Cov.:
33
AF XY:
AC XY:
23290
AN XY:
726698
show subpopulations
African (AFR)
AF:
AC:
1128
AN:
33480
American (AMR)
AF:
AC:
630
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
281
AN:
26136
East Asian (EAS)
AF:
AC:
29
AN:
39700
South Asian (SAS)
AF:
AC:
5375
AN:
86256
European-Finnish (FIN)
AF:
AC:
1786
AN:
52322
Middle Eastern (MID)
AF:
AC:
47
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
34288
AN:
1112004
Other (OTH)
AF:
AC:
1667
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
2981
5962
8944
11925
14906
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1274
2548
3822
5096
6370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0298 AC: 4539AN: 152206Hom.: 82 Cov.: 32 AF XY: 0.0302 AC XY: 2247AN XY: 74416 show subpopulations
GnomAD4 genome
AF:
AC:
4539
AN:
152206
Hom.:
Cov.:
32
AF XY:
AC XY:
2247
AN XY:
74416
show subpopulations
African (AFR)
AF:
AC:
1306
AN:
41502
American (AMR)
AF:
AC:
240
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
30
AN:
3472
East Asian (EAS)
AF:
AC:
12
AN:
5188
South Asian (SAS)
AF:
AC:
251
AN:
4820
European-Finnish (FIN)
AF:
AC:
381
AN:
10606
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2208
AN:
68014
Other (OTH)
AF:
AC:
36
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
210
419
629
838
1048
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
164
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
MHC class I deficiency Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.